Known targets — ChEMBL curated mechanism
CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D
The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | DAO | P14920 | 1/20 | 0.54 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.47 |
| ▸ | CES2 | O00748 | 2/20 | 0.47 |
| ▸ | CES1 | P23141 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.40 |
| ▸ | KDM6B | O15054 | 1/20 | 0.40 |
| ▸ | KDM4A | O75164 | 1/20 | 0.40 |
| ▸ | KDM5C | P41229 | 1/20 | 0.40 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.40 |
| ▸ | KDM3A | Q9Y4C1 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoic Acid SCHEMBL380582 | 0.93 | NAPRT (0.47) | NAPRTTSHRDAOSRD5A2CES2 | |
| Terephthalic Acid SCHEMBL27990724 | 0.92 | TSHR (0.50) | NAPRTTSHRDAOSRD5A2CES2 | |
| Terephthalic Acid SCHEMBL28067237 | 0.92 | TSHR (0.45) | NAPRTTSHRDAOSRD5A2CES2 | |
| Terephthalic Acid SCHEMBL28013542 | 0.90 | TSHR (0.48) | NAPRTTSHRDAOSRD5A2CES2 | |
| Terephthalic Acid SCHEMBL28044877 | 0.90 | TSHR (0.48) | NAPRTTSHRDAOSRD5A2CES2 | |
| Terephthalic Acid SCHEMBL28005997 | 0.90 | TSHR (0.48) | NAPRTTSHRDAOSRD5A2CES2 | |
| Terephthalic Acid SCHEMBL28065968 | 0.90 | TSHR (0.48) | NAPRTTSHRDAOSRD5A2CES2 | |
| Terephthalic Acid SCHEMBL27990425 | 0.90 | TSHR (0.42) | NAPRTTSHRDAOSRD5A2CES2 | |
| Isophthalic Acid SCHEMBL28050876 | 0.89 | CA12 (0.46) | NAPRTTSHRDAOALDH1A1HCAR2 | |
| Benzophenone SCHEMBL27762502 | 0.89 | ALDH1A1 (0.54) | SRD5A2ALDH1A1GAAKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118256961-A | Production method of double-sided roughened porous electrolytic copper foil | 九江德福科技股份有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118223094-A | Self-supporting strippable ultrathin carrier-attached copper foil and production method of copper-clad laminate | 九江德福科技股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| US-20200317976-A1 | NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE | MONASH UNIVERSITY (AU) | 2020-10-08 | — | — | US | claimed |
| EP-3458539-A1 | NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE | Monash University (AU) | 2019-03-27 | — | — | EP | claimed |
| WO-2017197438-A1 | NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE | MONASH UNIVERSITY (AU) | 2017-11-23 | — | — | WO | claimed |
| CN-118256961-A | Production method of double-sided roughened porous electrolytic copper foil | 九江德福科技股份有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118223094-A | Self-supporting strippable ultrathin carrier-attached copper foil and production method of copper-clad laminate | 九江德福科技股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-3177616-B1 | NOVEL ROUTES OF SYNTHESIS FOR THE PREPARATION OF SUVOREXANT | SANDOZ AG (CH) | 2021-02-24 | — | — | EP | disclosed |
| US-20200317976-A1 | NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE | MONASH UNIVERSITY (AU) | 2020-10-08 | — | — | US | disclosed |
| CN-106573882-B | Synthetic route to suvorexant | 桑多斯股份公司 | 2020-09-01 | — | — | CN | disclosed |
| EP-3458539-A1 | NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE | Monash University (AU) | 2019-03-27 | — | — | EP | disclosed |
| US-10030010-B2 | Route of synthesis for the preparation of suvorexant | SANDOZ AG (CH) | 2018-07-24 | — | — | US | disclosed |
| CN-107674037-A | The method of one kind 5 methyl 2 (triazoles of 2H 1,2,3) benzoic acid of synthesis | 四川大学 | 2018-02-09 | — | — | CN | disclosed |
| WO-2017197438-A1 | NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE | MONASH UNIVERSITY (AU) | 2017-11-23 | — | — | WO | disclosed |
| US-20170217947-A1 | Novel Route of Synthesis for the Preparation of Suvorexant | SANDOZ AG (CH) | 2017-08-03 | — | — | US | disclosed |
| EP-3177616-A1 | NOVEL ROUTES OF SYNTHESIS FOR THE PREPARATION OF SUVOREXANT | Sandoz AG (CH) | 2017-06-14 | — | — | EP | disclosed |
| CN-106573882-A | Novel routes of synthesis for preparation of suvorexant | 桑多斯股份公司 | 2017-04-19 | — | — | CN | disclosed |
| WO-2016020405-A1 | NOVEL ROUTES OF SYNTHESIS FOR THE PREPARATION OF SUVOREXANT | SANDOZ AG (CH) | 2016-02-11 | — | — | WO | disclosed |
| WO-2016020406-A1 | NOVEL ROUTES OF SYNTHESIS FOR THE PREPARATION OF SUVOREXANT | SANDOZ AG (CH) | 2016-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170217947-A1 | Novel Route of Synthesis for the Preparation of Suvorexant | CYP51A1, CYP3A5, HCRTR2 | NAPRT 578/4885TSHR 2424/4885DAO 440/4885 |
| US-10030010-B2 | Route of synthesis for the preparation of suvorexant | CYP51A1, CYP3A5, HCRTR2 | NAPRT 475/4885TSHR 2349/4885DAO 300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.